Trie authors conducted the largest study to date of survival in cystic fibrosis. The study cohort consisted of all patients with cystic fibrosis seen at Cystic Fibrosis Foundation-accredited care centers in the United States between 1988 and 1992 (n = 21,047), or approximately 85% of all US patients diagnosed with cystic fibrosis. Cox proportional hazards regression analysis was used to compare the age-specific mortality rates of males and females and to identify risk factors serving as potential explanatory variables for the gender-related difference in survival. Among the subjects 1-20 years of age, females were 60% more likely to die than males (relative risk = 1.6, 95% confidence interval 1.4-1.8). Outside this age range, male and female survival rates were not significantly different. The median survival for females was 25.3 years and for males was 28.4 years. Nutritional status, pulmonary function, and airway microbiology at a given age were strong predictors of mortality at subsequent ages. Nonetheless, differences between the genders in these parameters, as well as pancreatic insufficiency, age at diagnosis, mode of presentation, and race, could not account for the poorer survival among females. Even after adjustment for all these potential risk factors, females in the age range 1-20 years remained at greater risk for death (relative risk = 1.6, 95% confidence interval 1.2-2.1). The authors concluded that in 1-to 20-year-old individuals with cystic fibrosis, survival in females was poorer than in males. This "gender gap" was not explained by a wide variety of potential risk factors. Am J Epidemiol 1997; 145:794-803. cystic fibrosis; epidemiologic factors; mortality; sex factors; survival analysis During the past several decades, the life expectancy of patients with cystic fibrosis has improved dramatically (1). However, in the United States, Canada, and the United Kingdom, the mortality rate for females with this disease continues to exceed that of males (1-10). Although this "gender gap" has been well established, its etiology remains poorly understood. One previous study found an association between mucoid Pseudomonas aeruginosa respiratory colonization and gender-related survival differences (10). Otherwise, no prior study has aimed to identify explanatory factors for gender-related differences in survival.
During the past several decades, the life expectancy of patients with cystic fibrosis has improved dramatically (1) . However, in the United States, Canada, and the United Kingdom, the mortality rate for females with this disease continues to exceed that of males (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . Although this "gender gap" has been well established, its etiology remains poorly understood. One previous study found an association between mucoid Pseudomonas aeruginosa respiratory colonization and gender-related survival differences (10) . Otherwise, no prior study has aimed to identify explanatory factors for gender-related differences in survival.
The Cystic Fibrosis Foundation (CFF) maintains a registry of all patients with cystic fibrosis seen at CFF-accredited care centers in the United States. The registry currently includes approximately 85 percent of all diagnosed cases of cystic fibrosis in the United States (registry n = 20,096 in 1996) and more than 90 percent of deaths (1) . Because of its large size and comprehensive scope, this registry provides a unique opportunity to explore the gender difference in mortality in more detail and to investigate risk factors that might explain it. We hypothesized that differences in nutritional status (6, 9, 11) , respiratory microbiology (10) , and pulmonary function between the genders would explain some portion of the gender gap. Using 1988-1992 CFF registry data, this study compares the overall survival of males and females with cystic fibrosis in the United States, examines age-related trends in relative mortality rates, and investigates the role of a broad range of potential risk factors in explaining gender-related differences in survival.
MATERIALS AND METHODS

Subjects and data collection
Subjects were all individuals with cystic fibrosis who had been seen in a CFF-accredited care center
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between January 1, 1988 , and December 31, 1992 . The diagnosis was confirmed by either an elevated sweat chloride value (12) or a genotypic identification of two definable cystic fibrosis transmembrane conductance regulator mutations (13) . Each CFF-accredited care center is required to complete a standardized data form annually on all patients seen at its center during the previous year, and the results are entered into a computerized data base. Data for the current study were extracted from the registry in February 1995. A detailed account of the registry has been published elsewhere (1) .
Respiratory microbiology data were derived from sputum, throat, or bronchoscopic cultures. The majority were from sputum, whereas throat cultures were obtained from younger, nonexpectorating patients. Organisms were identified in accordance with the standards of the American Society for Microbiology or the National Committee for Clinical Laboratory Standards (14, 15) . Spirometry was performed according to American Thoracic Society standards (16) . Forced expiratory volume in 1 second (FEV,) and forced vital capacity (FVC) were analyzed as percentages of predicted values based on gender and height, calculated using a modification of the Knudson equations (17), which removes the lower boundary for height for ageand sex-specific groups (1). Spirometry can be performed reliably only in subjects ^5 years of age, and infant pulmonary function tests are not included in the registry.
Height and weight Z scores, based on National Center for Health Statistics reference curves (18) , were computed using the anthropometric statistical package of the Centers for Disease Control (19) . Leanness was assessed by computing weight as a percentage of ideal weight for height and gender (percentage of ideal body weight) using the methods of Moore et al. (20) .
Analysis
The analysis was carried out in four phases. First, the unadjusted relative risk of death for females compared with males at each age was computed using Cox proportional hazards regression analysis methods (21) . In addition, plots of survival by gender were generated using the "current" life table method, employing 1-year age intervals. Second, the prevalence of potential explanatory factors was compared between the genders using the t test for two independent samples, or Pearson's x 2 test to compare proportions, with Bonferroni's correction for multiple comparisons. Third, the independent effect of each potential explanatory factor on risk of death was assessed through Cox regression analyses. Finally, Cox regression analysis was used to investigate the relative risk of death for females compared with males after controlling for the potential explanatory variables.
Survival analyses were of the current survival type, with the time scale age in years. In other words, because subjects entered the cohort at different ages, all observation times were left-entered by age at entry into the cohort so that patients contributed personyears to the analysis only at ages corresponding to their actual ages during the study period. Age at entry into the cohort was defined as the age at the first visit to a CFF care center during the study period for those diagnosed before 1988, or the age at cystic fibrosis diagnosis for those subjects diagnosed during the study period. This current survival analysis technique avoids the bias introduced into prevalent cohort analyses by assuming that all patients are followed from time zero (22) . Because the CFF registry has been shown to capture greater than 90 percent of patient deaths (1), subjects not recorded as dying during the study period were assumed to be alive at the end of it. These subjects were censored at their age on December 31 of the last year in the study period in which they had a visit to a CFF care center.
Potential explanatory variables were classified with regard to time as either time-independent (fixed with regard to time) or time-dependent. Time-independent variables included race (white, nonwhite); genotype (homozygous AF508, heterozygous AF508, other); mode of presentation (gastrointestinal symptoms (meconium ileus, failure to thrive, steatorrhea, rectal prolapse, or hepatic dysfunction), respiratory symptoms (acute or chronic pulmonary symptoms, nasal polyposis, or sinus disease), mixed gastrointestinal and respiratory symptoms; sweat chloride value (<60 mEq/liter, 60-80 mEq/liter, >80 mEq/liter); age at diagnosis (quartiles of distribution in the study population); and pancreatic insufficiency (present, absent). Time-dependent variables included FVC (percentage of predicted (normal or >80 percent, mildly reduced or 60-80 percent, moderately reduced or 40-59 percent, severely reduced or <40 percent); FEV, (percentage of predicted (normal or >80 percent, mild obstruction or 60-80 percent, moderate obstruction or 40-59 percent, severe obstruction or <40 percent); P. aeruginosa in respiratory culture (present, absent); Burkholderia cepacia in respiratory culture (present, absent); height Z score; weight Z score; and percentage of ideal body weight. Height and weight Z scores and percentages of ideal body weight were categorized into quartiles of the observed distributions in the study population, with the lowest quartile further divided into values more than and less than the tenth percen-tile. Pulmonary function and anthropometric measures were analyzed as categorical ("dummy") variables to permit a nonlinear relation between variable values and risk of death. Similar conclusions were reached with continuous variables.
To more fully explore the effect of time-dependent covariates on relative mortality rates, covariate values were lagged 1-4 years (the maximum possible lag) in separate Cox regression analyses. As all lag times produced similar results, models incorporating a 2-year lag are presented. In other words, for all timedependent covariates, when comparing the covariate values of those dying at age t with those still alive and under observation at age t, the covariate values at age t -2 were used as predictors. Only subjects followed for at least 2 years are included in the analyses involving time-dependent covariates.
The addition of interaction terms between gender and each potential explanatory factor was assessed with the likelihood ratio statistic. The assumption of proportionality was tested by including a timedependent compound variable defined as the product of gender and age. The significance level was set at 0.05, and all p values were two tailed. Analyses were carried out using the SAS PHREG (23) procedures on the University of Washington mainframe computer and SPSS 6.0 (24) and STATA 3.1 (25) on an IBMcompatible personal computer.
RESULTS
The cohort was composed of 21,047 subjects seen at CFF care centers between January 1988 and December 1992. They were followed for a mean duration of 45 (range 12-60) months, and 10,528 (49 percent) were followed for all 5 years. There were 1,690 deaths during the study period. Age (years) 
Unadjusted gender-related relative mortality rates
Overall, female survival was poorer than that of males (figure 1), with a median survival for females of 25.3 years and for males, 28.4 years. In addition, relative mortality rates varied by age (table 1) . Females had significantly poorer survival than males for all age intervals between 1 and 20 years. Outside this age range, male and female mortality rates were not significantly different, although there was a suggestion of poorer survival among males younger than 1 year (risk of death for females relative to males = 0.6, 95 percent confidence interval (CI) 0.3-1.5). Causes of death were similar for males and females. Between the ages of 1 and 20 years, 77 percent of male and 82 percent of female deaths were related to respiratory causes; 4 and 3 percent, respectively, were transplant related; 3 and 2 percent, liver related; 1.8 and 1 percent due to trauma or suicide; and 15 and 12 percent of unknown or other causes.
Comparison of potential explanatory factors between genders
The prevalence of potential risk factors was not higher among females than males. There was no difference between males and females in the distributions of age at diagnosis, mode of presentation, pancreatic Am J Epidemiol Vol. 145, No. 9, 1997 insufficiency, genotype, race, or sweat chloride value (table 2). The median age at diagnosis for males was 6.4 months (range 0-67.2 years) and for females, 6.7 months (range 0-70.6 years).
Males and females in all age groups were more poorly nourished than the general US population, with the age-and gender-standardized measures of height and weight far below those of the reference population means (table 3) . In general, however, females in the cohort actually appeared to have better nutritional status (mean height and weight Z scores and percentage of ideal body weight) than males older than 16 years, particularly in the age range 16-25. For those younger than 16, there was no clear-cut pattern in the distribution of mean values by gender. Pulmonary function appeared better in males than females in the younger age groups (6-15 years for FEVj and 11-15 for FVC) and better in females than males in the older age groups (older than 21 years for FEVj and 26 years for FVC). The only risk factor for which there was a higher prevalence among females was P. aeruginosa colonization in the age range 6-15 years. There was no clear pattern in B. cepacia colonization (data not shown).
Association of each potential explanatory factor with risk of death
The association of each potential prognostic factor alone with risk of death is shown in table 4. Risk estimates are from univariate Cox survival analyses that include one factor at a time in the analysis. Because the excess risk of death in females was limited to ages 1-20 years, Cox analyses were restricted to this age range, in which 771 of the 1,690 observed 
Effect of potential explanatory factors on the gender-related risk of death
Pulmonary function was the only risk factor that explained a portion of the observed gender-related difference in survival. Among subjects in whom spirometry was recorded, the risk of death for females compared with males was 1.7 (95 percent CI 1.3-2.2). After adjustment for FEV, and FVC, this relative risk decreased to 1.5 (95 percent CI 1.2-1.9). Adjustment for all of the other risk factors, alone or in combination, did not reduce the gender-related relative risk from its unadjusted value. After adjustment for all potential explanatory variables, females remained 60 percent more likely to die than males (relative risk = 1.6, 95 percent CI 1.2-2.1). In this fully adjusted model (i.e., the analysis incorporates all potential explanatory factors except genotype), gender, FEV,, height Z score, respiratory colonization with both P. aeruginosa and B. cepacia, and pancreatic insufficiency were significantly associated with risk of death (table 5). Genotype was not included in multivariate analyses due to the large number of missing values (76 percent of subjects). No interaction term between gender and any potential explanatory factor was significant
DISCUSSION
To date, this is the largest study to examine survival in cystic fibrosis and the first to investigate the role of a variety of risk factors in explaining gender differences in survival. Among 21,047 cystic fibrosis patients in the United States followed between 1988 and 1992, we have shown an excess risk of death for females compared with males aged 1-20 years. Poorer female survival in cystic fibrosis has been reported previously by investigators from the United States (1, 2,4, 10), Canada (3, 6, 9) , and the United Kingdom (5, 7, 8) , from the 1960s to the 1980s. A few studies have failed to find an association between gender and risk of death (26) (27) (28) (29) (30) (31) (32) (33) , but many of these were small investigations in which a trend, albeit nonsignificant, toward poorer female survival was demonstrated (31) (32) (33) . Although male and female median survival among all CFF registry subjects was similar in 1994 (34) , median survival among these subjects in 1995 was 31.1 years for males and 28.3 years for females (35) , similar to the last 8 years.
The large size of our study population enabled us to evaluate age-related trends in relative mortality rates. As qualitatively noted previously (4, 6, 7, 32), we found poorer female survival to be limited to those subjects younger than 20 years, suggesting that the forces behind excess female mortality act most strongly at an early age. There was also a trend within this range for the relative risk to become less with increasing age (table 1) . Although it has been postulated (6) that hormonal differences between the genders play a significant role in explaining poorer female survival, our findings of substantially poorer female survival before puberty do not support this conjecture. Perhaps ongoing and future studies of less airway inflammation and infection in young children with cystic fibrosis will help to illuminate the reason for the observed difference in gender effects at different ages.
The suggestion of greater male mortality in subjects younger than 1 year of age has been noted previously (5) . This poorer male survival among cystic fibrosis infants may be mediated through viral lower respiratory infections, an important cause of mortality in infants with cystic fibrosis and a cause of greater male morbidity in infants without cystic fibrosis (36) . It may also reflect the higher male infant mortality rate in the general population (37) .
A wide variety of potential explanatory factors were examined in terms of their impact both on overall mortality and gender-related differences. Nutritional status, pulmonary function, and respiratory microbial colonization patterns were highly prognostic of survival. Pancreatic insufficiency was also associated with an increased risk of death in analyses including all potential risk factors (table 5) ; however, these prognostic factors were unable to explain the greater relative mortality of females in the present analysis. Differences in pulmonary function did appear to explain a small portion of the excess female mortality, but no other factor further accounted for the gender gap. 
Table 4 continues
Others have hypothesized that poorer nutrition in females, demonstrated in several earlier Canadian studies (6, 9, 11), might explain their higher mortality rate. Kerem and colleagues (9) found that poorer female nutritional status explained a large portion of excess female mortality among 673 Canadian subjects followed between 1977 and 1989. In the current study, female nutrition did not appear poorer than that of males. Although both genders were undernourished compared with the general population, males and females had similar height and weight percentiles in the younger age groups, and females with cystic fibrosis actually appeared slightly better nourished than males older than 16 years, particularly in the age range 16-25. Older females also appeared to have better pulmonary function than males. Perhaps the better nutrition and pulmonary function of older females relative to males represents selective survival.
Although the improved female nutrition relative to males seen in the current study is encouraging, it was not associated with a reduction in the relative mortality of females compared with males. Thus, unidentified factors other than differences in nutritional status appear to be responsible for the excess female mortality in the current study population.
Nutritional interventions have changed in the United States over the past 15 years, from a low fat to a higher fat diet, with proportionately more pancreatic enzyme f Categorized by quartile of distribution in the cohort with the lowest quartile of height and weight Z scores further divided above and below the 10th percantile.
i NS, nonsignificant; FEV,, forced expiratory volume in 1 second. § Pertain to risk of death 2 years after the measurement was made.
supplementation (38) . If improvements in female nutrition due to these interventions were to affect genderrelated relative mortality rates, one would expect this trend to be evident in the current study population, as excess female mortality is most pronounced in the youngest subjects who were bom after the changes in dietary practices. The particularly poor nutritional status of both genders in infancy has been noted by other investigators (2, 11) and may reflect untreated pancreatic insufficiency at the time of diagnosis. The one potential explanatory factor found in our study to have a higher prevalence among females was P. aeruginosa respiratory colonization among subjects 6-15 years of age. Demko and colleagues (10) similarly found respiratory colonization by mucoid P. aeruginosa to be earlier in females than in males • Forced vital capacity, height (Z score), weight (Z score), % of kteal body weight, age at diagnosis, mode of presentation, pancreatic insufficiency, and race were also included in the model. Relative risks associated with these variables were nonsignificant Analysis includes data for ages 1-20 years.
t FEV t , forced expiratory volume in 1 second; NS, nonsignificant. X Relative risks pertain to risk of death 2 years after the measurement was made. § Categories reflect quart'les of observation distribution in the cohort, with the lowest quartile further divided above and below the 10th percentile.
among 848 patients. They posited that earlier acquisition of this more virulent form of the bacteria by females could in part explain their poorer survival. Alternatively, earlier colonization with P. aeruginosa could be a marker of more severe disease among females. Future research on gender differences might investigate more sensitive measures of pseudomonal respiratory colonization, such as bronchoscopic cultures or indication of mucoid phenotype, to explain a portion of the excess female mortality in cystic fibrosis.
Prior studies have shown colonization with B. cepacia (39), but not P. aeruginosa (10) , to affect survival among females more negatively than males. Although we found strong negative impacts of B. cepacia and P. aeruginosa colonization on overall survival, the effects were not different between the genders. In fact, none of the factors evaluated was more predictive of mortality in one gender than the other.
The observed higher female mortality rate could be due to ascertainment bias if more females had a milder form of cystic fibrosis and were therefore less likely to be seen at CFF-accredited care centers. However, the gender difference in mortality noted in the current study has been corroborated by population-based studies in Canada (3, 6, 9) and the United Kingdom (5, 7, 8) where, because of differences in the provision of health services, coverage is more complete.
Although our population-based study of survival in cystic fibrosis is the largest to date, it has certain limitations. First, the characterization of factors analyzed for their potential effect on survival was limited to height and weight, spirometry, and sputum or throat cultures collected on an annual basis. Genotyping was not performed in a systematic fashion, although there is no reason to believe that indications for genotyping differed between the genders. We also lacked data on certain factors shown in previous studies to affect lung function, such as exercise (40) or passive smoking (41), or to affect survival, such as treatment regimens (7), socioeconomic status (8), or extent of lung disease at diagnosis (33) . Patients in our study were followed for a maximum of 5 years, limiting the investigation of latent periods for the effect of potential explanatory factors on survival. As cystic fibrosis is characterized by slow declines in pulmonary function and nutrition over many years, it would be informative to evaluate the predictive effect of pulmonary and nutritional status on survival 5 or 10 years hence.
In conclusion, we found poorer survival in females than males between the ages of 1 and 20 years. This Am J Epidemiol Vol. 145, No. 9, 1997 gender gap is most likely multifactorial in etiology. Although differences in pulmonary function between the genders appeared to explain a small portion of the excess female mortality, other etiologic mechanisms remain elusive. Additional research should be directed toward their identification as well as the evaluation of longer latency periods.
